Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months

    April 28, 2026

    Taylor Swift files to trademark her voice, likeness to ward off AI deepfakes

    April 28, 2026

    With new patch design, the Crew-13 astronauts clearly aren’t superstitious

    April 28, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Business»European markets: Stoxx 600, FTSE, DAX, CAC, Iran latest news
    Business

    European markets: Stoxx 600, FTSE, DAX, CAC, Iran latest news

    franperez66q@protonmail.comBy franperez66q@protonmail.comApril 28, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email


    LONDON — European stocks are expected to open higher on Tuesday as investors await Washington’s response to Iranian peace proposals and look ahead to earnings reports from several regional companies.

    The U.K.’s FTSE 100 index is seen opening a touch higher, with Germany’s DAX up 0.23%, France’s CAC 40 up 0.34% and Italy’s FTSE MIB 0.3% higher, according to data from IG.

    Earnings come from Novartis, Airbus, BP and Barclays on Tuesday.

    Investors will be assessing the news that U.S. President Donald Trump and his national security team discussed Iran’s proposal to reopen the Strait of Hormuz if the U.S. lifts its blockade and the war ends, White House press secretary Karoline Leavitt confirmed on Monday.

    The proposal would postpone negotiations on Tehran’s nuclear ambitions for a later date, Axios and The Associated Press reported earlier in the session.

    It’s unclear whether Trump, who has vowed not to lift the blockade until a deal with Iran is “100% complete,” entertained the reported offer to end the two-month-old war. Oil prices edged higher overnight as uncertainty lingered over the outcome of the war.

    In corporate news, German biotechnology giant Bayer went before the U.S. Supreme Court on Monday in a bid to bring thousands of lawsuits against its herbicide Roundup to an end.

    Bayer acquired Roundup maker Monsanto for $63 billion in 2018 and has faced years of litigation since the deal was completed, amid claims that glyphosate, an ingredient in the weedkiller, has been the cause of health issues, including cancer.

    Justices were reportedly divided after hearing arguments in Monday’s hearing, during which Bayer laid out its appeal against a Missouri court’s award of $1.25 million to a man who said years of exposure to Roundup were behind his non-Hodgkin lymphoma diagnosis.

    Activists for the “Make America Healthy Again,” or MAHA, movement, gathered outside the court on Monday to protest against Bayer.

    Swiss drugmaker Novartis reported its first-quarter earnings on Tuesday, with group operating income dropping 12% on an annual basis to $4.9 billion.

    It fell below the $5.3 billion expected by analysts polled by LSEG.

    British oil major BP also reported first-quarter earnings on Tuesday, with the company’s profits for the quarter more than doubling and beating expectations.

    Global market attention will also be focusing on central banks this week, with the U.S. Federal Reserve, European Central Bank and Bank of England all due to hold pivotal meetings as the war upends inflation and growth expectations.

    The Fed’s policy decision on Wednesday could mark Jerome Powell’s final meeting as chair before Kevin Warsh is expected to take over in May. The Department of Justice decided to drop its criminal probe into Powell on Friday, causing Sen. Thom Tillis to end his block of Warsh’s confirmation.

    The ECB and BOE both publish their latest monetary policy decisions on Thursday, with economists expecting the central banks to stand pat on their benchmark interest rates at their respective meetings this month. However, the central banks are expected to leave the door open to hikes later this year.

    — CNBC’s Kevin Breuninger contributed to this market report.

    Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months

    April 28, 2026

    Oil major BP beats profit expectations as Iran war boosts fuel prices

    April 28, 2026

    Meta, Google among Big Tech seeing staff leave to launch own AI labs

    April 28, 2026

    General Motors (GM) earnings Q1 2026

    April 28, 2026

    CATL shares slide after $5 billion Hong Kong share placement plan

    April 28, 2026

    BYD draws EU scrutiny over labor abuse allegations at Hungary factory

    April 28, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months

    April 28, 2026

    Taylor Swift files to trademark her voice, likeness to ward off AI deepfakes

    April 28, 2026

    With new patch design, the Crew-13 astronauts clearly aren’t superstitious

    April 28, 2026

    'Some form' of social media restrictions for under-16s, minister promises

    April 28, 2026
    © 2026 All right reserved
    • About Us
    • Privacy Policy
    • Terms & Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.